Fairweather D S, Bradwell A R, Dykes P W, Vaughan A T, Watson-James S F, Chandler S
Br Med J (Clin Res Ed). 1983 Jul 16;287(6386):167-70. doi: 10.1136/bmj.287.6386.167.
Immunoglobulin G (IgG) antibodies to carcinoembryonic antigen (CEA) were labelled with radioactive indium (111In) or iodine (131I) and a comparison made of their value in locating CEA producing tumours. Eleven patients given 111In-anti-CEA had 31 tumours as judged by a combination of all techniques. Of these, 28 were detected by 111In-anti-CEA and 26 by conventional clinical techniques. Five of the patients also received 131I-anti-CEA. These patients had 15 tumour areas. Thirteen were detected by 111In and eight by 131I. 111In also produced a better signal to noise ratio in the scans and thereby showed lesions with greater certainty. In addition, the 111In isotope continued to accumulate in the tumour areas for considerably longer than 131I. Absorbed doses (whole body) were similar for both isotopes. The results show that antibody scanning is greatly improved by using 111In as the radiolabel in place of 131I and should allow the detection of smaller or deeper lesions.
用放射性铟(111In)或碘(131I)标记癌胚抗原(CEA)的免疫球蛋白G(IgG)抗体,并比较它们在定位产生CEA的肿瘤中的价值。通过所有技术综合判断,11名接受111In - 抗CEA治疗的患者有31个肿瘤。其中,28个由111In - 抗CEA检测到,26个由传统临床技术检测到。5名患者还接受了131I - 抗CEA治疗。这些患者有15个肿瘤区域。13个由111In检测到,8个由131I检测到。111In在扫描中还产生了更好的信噪比,从而更确定地显示病变。此外,111In同位素在肿瘤区域的积累持续时间比131I长得多。两种同位素的全身吸收剂量相似。结果表明,用111In代替131I作为放射性标记可大大改善抗体扫描,并且应该能够检测到更小或更深的病变。